Abstract Coronavirus Disease 19 (COVID-19) is a respiratory disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has grown to a worldwide …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health
issue. COVID-19 is considered an airway/multi-systemic disease, and demise has been …

Systematic autopsy and comprehensive pathological analyses of COVID-19 decedents
should provide insights into the disease characteristics and facilitate the development of …

Some patients hospitalized with acute COVID-19 suffer respiratory symptoms that persist for
many months. We delineated the immune-proteomic landscape in the airways and …

Coronavirus disease 2019 (COVID-19), the global pandemic caused by SARS-CoV-2, has
resulted thus far in greater than 933,000 deaths worldwide; yet disease pathogenesis …

Respiratory tract infection with SARS-CoV-2 results in varying immunopathology underlying
COVID-19. We examine cellular, humoral and cytokine responses covering 382 immune …

Background Knowledge of the pathophysiology of COVID-19 is almost exclusively derived
from studies that examined the immune response in blood. We here aimed to analyse the …

The clinical manifestation of coronavirus disease 2019 (COVID‐19) mainly targets the lung
as a primary affected organ, which is also a critical site of immune cell activation by severe …

Severe coronavirus disease 2019 (COVID-19) pneumonia survivors often exhibit long-term
pulmonary sequelae, but the underlying mechanisms or associated local and systemic …

Immunopathology occurs in the lung and spleen in fatal coronavirus disease (COVID-19),
involving monocytes/macrophages and plasma cells. Antiinflammatory therapy reduces …